News About: Pharm. Industry
Kangstem Biotech selected by ‘F1000Prime’ for its publication about rheumatoid arthritisKangstem Biotech announced on the 8th that a paper about ‘Furestem-RA,’a rheumatoid arthritis stem cell treatment being developed by the company, was selected as an excellent pa...
|
Daewoong, “Nabota counterfeits were exposed by investigative agency”Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced a group of people who made counterfeit ‘Nabota’ products was arrested and confirmed distribution of these products to China....
|
Pfizer Pharmaceuticals Korea carry out patent support program of ‘Ibrance,’ breast cancer treatmentPfizer Pharmaceuticals Korea will start a patient support program for ‘Ibrance(generic name: palbociclib),’ a breast cancer therapy.
According to the company, it internally had...
|
Will pharma industry’s dream of having presidential committee come true
The 19th Presidential Election will be held on the 9th, which has drawn attention of the pharmaceutical industry as well. Who will be elected is an interest of the nation, but each industry has their expectation on th...
Pharma industry’s SG&A expenses accounting for 30.5% of total sales
It was observed the pharmaceutical companies’ SG&A(selling, general and administrative) expenses, which reached about 30% of their sales, have been a factor that blocks the way from increasing profitability.
Accordin...
166 pharmas record 6.3% operating profit rate, earning KRW 63 out of making KRW 1k sales
Pharmaceutical companies were analyzed to generate KRW 63 out of selling products, including both goods and merchandises, worth of KRW 1,000 last year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result...
Yuhan Corporation founds ‘Yuhan Philia’ specializing in beauty and health
Yuhan Corporation(CEO Jung-Hee Lee) announced foundation of ‘Yuhan Philia,’ a company specializing in beauty and health on the 1st.
In order to secure future growth power and specify its business diversification stra...
67 pharmas with more than KRW 100 billion sales despite 18 companies with less than 20 million
Pharmaceutical companies which turned in an audit report to the Financial Supervisory Service last year reportedly raised sales by 9.5% on average, but decreased operating profits and net profits by 1.1% and 5.6%, res...
Unlisted pharmas improved profitability by reducing SG&A expenses
It was observed that unlisted pharmaceutical companies, where most of them are small and medium companies, were able to raise profitability by reducing ‘selling, general and administrative(SG&A) expenses.’
According ...
Dong Wha Pharm signs exclusive sales agreement of Plavix to clinics in Korea with Sanofi-Aventis
Dong Wha Pharm(CEO Ji-Hoon Sohn) signed an exclusive distribution and sales agreement of Plavix(generic name: clopidogrel bisulfate), an anti-platelet drug, to Korean clinics with Sanofi.Aventis Korea(CEO Kyung-Eun Ba...
